Ditch Labs Wins The Jury’s First Prize Following Acfas Competition’s 6th Edition

MONTREAL, QC/March, 2022 – The 6th edition of Acfas competition occurred on March 29th and was broadcasted live.

Following the event, the research team of Ditch Labs, Inc. led by Research Director and Partner Christelle Luce, Co-Founder and CTO Olivier Bourbonnais, Pharmacologist Mehdi El Hassani, Researcher in Psychology Éric Hanigan and Financial Analyst Naïl Sousa Cordeiro as part of the 6 finalist teams, wins the jury’s first prize. The prize includes a value of more than $22,000 in consulting and scholarship services. The company sincerely thanks Acfas and the jury for the opportunity to participate.

“We couldn’t be happier following the performance of our research team which includes Christelle Luce, P.h.D, Olivier Bourbonnais, Mehdi El Hassani, Éric Hanigan and Naïl Sousa Cordeiro during yesterday’s competition of Acfas. It is an honor to have participated and to be the winning team of the jury’s first prize! Congratulations to all the participants and thanks to the jury for their time and support.” - Ditch Labs, Public Statement

Ditch Labs Announced As Finalist Of ACFAS Competition’s 6th Edition

MONTREAL, QC/March, 2022 – Led by Research Director and Partner Christelle Luce, Co-Founder and CTO Olivier Bourbonnais, Pharmacologist Mehdi El Hassani, Researcher in Psychology Éric Hanigan, Financial Analyst Naïl Sousa Cordeiro and Medical Devices Consultant Jean-Pierre Desmarais, Ditch Labs, Inc. becomes finalist of the renowned Génies en affaires competition which will occur live on Facebook on March 29th, 2022. The event will include a 5-minute question period following an 80-second sales pitch and a vote from the public to choose the winners.

Ditch Partners With The CRIQ, Investissement Québec's World-Renowned Laboratory, For Nonclinical Testing

MONTREAL, QC/January, 2022 – Ditch Labs, Inc.’s partnership with the CRIQ led by Research Director and Partner Christelle Luce, Co-Founder and CTO Olivier Bourbonnais and Pharmacologist Mehdi El Hassani, will serve the objective of characterizing the aerosol generated by the DitchPen™. The company intends to present a toxicology report to the FDA and Health Canada in order to receive a Clinical Trial Authorization (Health Canada) and an Investigational New Drug approval (FDA).

Ditch Labs Receives Funding From The National Research Council's IRAP Program

MONTREAL, QC/December, 2021 – Following the partnership between Ditch Labs, Inc. and the CRIM along with professional recommendations, the company’s application for the non-dilutive funding of the National Research Council’s IRAP program is now approved. These additional funds will finance the fees of the CRIM researchers.

Ditch Opens Up New Headquarters In Montreal

MONTREAL, QC/September, 2021 – Ditch Labs, Inc. opens up new headquarters located on Prince Arthur Street in Montreal following a virtual staff growth from 3 to 15 employees during the pandemic. The offices will include electronic, server and computational laboratories to serve all research and hardware initiatives. This new location will allow proximity to all downtown activities along with more accessibility for staff and team collaborators.